Tales from the Heart

Generic Drug Risks and Patient Safety

Lisa Salberg and Dr. Harry Lever take a hard look at generic drug quality and why consistency matters for people living with HCM. They break down real-world risks, what patients should watch for at the pharmacy, and how policy changes could improve safety nationwide.

 

This conversation was recorded April 17, 2026.

New Trial Targets Symptoms Beyond Obstruction

Lisa Salberg and Dr. Ahmed Masri break down the SONATA HCM clinical trial and a new approach that targets metabolism, not just pressure, in the heart. They explain who may qualify, what to expect, and why patient participation is critical to advancing better treatments for both obstructive and non-obstructive HCM.

 

This conversation was recorded April 14, 2026

New Therapies and What Comes Next

Lisa Salberg and Dr. Marty Maron break down the latest HCM developments from ACC, including emerging myosin inhibitors, AI in imaging, and new approaches to fibrosis and genetic therapies. They also explain what these advances mean for patients now and how to prepare for a rapidly evolving treatment landscape.

 

This conversation was record April 10, 2026

Planning Ahead With HCM: What Matters Most

Lisa Salberg and Dr. Alex de Feria walk through how patients can stay proactive with hypertrophic cardiomyopathy—from annual testing and symptom tracking to understanding when to act. They break down real-world decision making, hidden symptoms, and how evolving care strategies can help patients stay ahead of their condition.

 

This conversation was recorded March 26, 2026.

Arrhythmias and Evolving HCM Treatment Strategies

Lisa Salberg and Dr. Marty Maron break down new research reshaping how HCM is treated, from long-standing beta blockers to emerging targeted therapies. They also walk through arrhythmia risks, monitoring, and prevention—giving patients a clearer roadmap for managing symptoms and long-term outcomes in a rapidly changing care landscape.

Conversation recorded March 13, 2026

Heart Health, Family History, and Action

Lisa Salberg sits down with Senator Anthony Bucco to discuss why Heart Month and knowing your family heart health history can save lives. They explore New Jersey’s leadership in cardiac screening laws, the importance of early detection for HCM, and ongoing efforts to improve insurance access and patient protections.

 

This conversation was recorded Feb. 20, 2026.

Awareness, Action and the Future of HCM

Lisa Salberg and Dr. Marty Maron reflect on Heart Month, HCM Awareness Day, and the rapid evolution of treatment options. They discuss new therapies, clinical trials, patient empowerment, and why clarity and lifelong care remain essential in the journey with hypertrophic cardiomyopathy.

 

This conversation was recorded Feb. 20, 2026.

Living and Leading With HCM

Lisa Salberg and Dr. Marty Maron reflect on Heart Month, HCM Awareness Day, and the rapid evolution of treatment options. They discuss new therapies, clinical trials, patient empowerment, and why clarity and lifelong care remain essential in the journey with hypertrophic cardiomyopathy.

 

This conversation was recorded Feb. 13, 2026

Living and Leading With HCM

Host Lisa Salberg talks with author Dr. Matt Martinez about living with hypertrophic cardiomyopathy while balancing family, career, and advocacy. The conversation explores personal perspective, patient empowerment, and how sharing lived experience can help others better understand and navigate an HCM diagnosis.

 

This conversation was recorded Feb. 6, 2026.

A Mother’s Story of Loss, Love, and HCM

Host Lisa Salberg talks with author and educator Dr. Mary Massey about the loss of her son to sudden cardiac arrest and the book she wrote to honor his life and help other families understand hypertrophic cardiomyopathy. Their conversation explores grief, genetic risk, ongoing screening, and how sharing one story can help protect others.

 

This conversation was recorded Feb. 2, 2026.